Percutaneous Transseptal Bioprosthetic Implantation in Failed Prosthetic Surgical Mitral Valve - Brazilian Multicenter Experience.
Pedro Felipe Gomes NiczPedro Henrique M Craveiro de MeloPedro Henrique Ferro de BritoEliane Nogueira LimaRicardo Cavalcante E SilvaMaurício Lopes PrudenteFernando Henrique FernandesMaurilio Onofre DeiningerMarcelo Antonio Cartaxo Queiroga LopesFúlvio Soares PetrucciFernando Roquette Reis FilhoMarcos Antonio MarinoRodrigo de Castro BernardesEduardo Pessoa de MeloMarco Antonio Praça OliveiraJosé Armando MangioneFernanda Marinho MangioneCarlos Henrique Eiras FalcãoEstêvão Carvalho de Campos MartinsWalter LunardiFernando BacalFlávio TarasoutchiFábio Sândoli de Brito JuniorPublished in: Arquivos brasileiros de cardiologia (2020)
The first Brazilian experience with transseptal-TMVIV shows the safety and effectivity of the new technique. The LVOT obstruction is a potentially fatal complication, reinforcing the importance of patients' selection and of procedural planning. (Arq Bras Cardiol. 2020; [online].ahead print, PP.0-0).
Keyphrases
- mitral valve
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- social media
- aortic valve
- left atrial
- peritoneal dialysis
- healthcare
- prognostic factors
- aortic valve replacement
- left ventricular
- cross sectional
- minimally invasive
- health information
- clinical trial
- transcatheter aortic valve replacement